Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Sherman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Psychogeriatrics|April 19, 2017
Prevalence, neurobiology, and treatments for apathy in prodromal dementiaChelsea Sherman, Celina S Liu, Nathan Herrmann, et al.
Current Opinion in Psychiatry|December 20, 2017
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementiaChelsea Sherman, Myuri Ruthirakuhan, Danielle Vieira, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 18, 2017
Antipsychotic Use in DementiaJulia Kirkham, Chelsea Sherman, Clive Velkers, et al.
Plos One|September 23, 2016
The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-AnalysisAdam Dinoff, Nathan Herrmann, Walter Swardfager, et al.
Journal of Alzheimer'S Disease : JAD|November 12, 2016
Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease PatientsSarah A Chau, Nathan Herrmann, Chelsea Sherman, et al.
Translational Psychiatry|May 20, 2020
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disordersAndré F Carvalho, Marco Solmi, Marcos Sanches, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Psychogeriatrics|April 19, 2017
Prevalence, neurobiology, and treatments for apathy in prodromal dementiaChelsea Sherman, Celina S Liu, Nathan Herrmann, et al.
Current Opinion in Psychiatry|December 20, 2017
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementiaChelsea Sherman, Myuri Ruthirakuhan, Danielle Vieira, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 18, 2017
Antipsychotic Use in DementiaJulia Kirkham, Chelsea Sherman, Clive Velkers, et al.
Plos One|September 23, 2016
The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-AnalysisAdam Dinoff, Nathan Herrmann, Walter Swardfager, et al.
Journal of Alzheimer'S Disease : JAD|November 12, 2016
Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease PatientsSarah A Chau, Nathan Herrmann, Chelsea Sherman, et al.
Translational Psychiatry|May 20, 2020
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disordersAndré F Carvalho, Marco Solmi, Marcos Sanches, et al.
Pageof 1